Jun 01, 2021 02:25 PM IST
Given the expected strong momentum, experts advise top 14 stock picks that are available at attractive valuations now
- May 25, 2021 07:23 AM IST
Nifty Midcap and Smallcap indices have outperformed Nifty in this calendar year so far. We expect their outperformance to continue. Here are three buy recommendations from the mid and smallcap segment
- Feb 16, 2021 07:21 AM IST
Bullish technical set up is seen not only for Indian markets, but across the globe. Short-term traders are advised to focus on 15,470 levels as resistance for the Nifty50 index.
- Feb 11, 2021 03:41 PM IST
Every sector participated in the run seen this month, given expected recovery in earnings and economy after slew of measures announced in last one year.
- Sep 06, 2020 12:35 PM IST
Though the negative bias is expected in the short term but stock-specific opportunities are likely to keep the traders in high spirits.
- Dec 05, 2017 07:23 AM IST
Moneycontrol undertook an analysis to show that there have been expensive stocks that have given stellar returns to their investor in the last 3 years.
- Nov 20, 2017 08:37 AM IST
Mitessh Thakkar 0f mitesshthakkar.com has a buy on Ajanta Pharma with a stop loss of Rs 1237, target of Rs 1360 and a buy on DLF with a stop loss of Rs 215, target of Rs 245.
- Nov 20, 2017 08:11 AM IST
According to technical analyst Prakash Gaba of prakashgaba.com, for the Nifty, the trend is up as long as 10175 holds and upside to 10340 is also a possibility. The crucial support for the Nifty is at 10175-10089 and the resistance is at 10340. Bank Nifty on the other hand has support at 25600 and resistance at 26000.
- Nov 17, 2017 03:07 PM IST
Prakash Gaba of prakashgaba.com feels that Blue Dart can climb to Rs 4200.
- Aug 24, 2017 09:54 AM IST
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ashok Leyland, HDFC, Vedanta and Canara Bank and sell Cummins India.
- Jul 28, 2017 11:03 AM IST
A decline in margins resulted in consolidated profit declining by 52 percent YoY to Rs 21.1 crore in June quarter.
- Jul 28, 2017 08:58 AM IST
ITC, ICICI Bank, Dr Reddy’s Labs and ONGC, among others, are on the radar of investors on Friday.
- Apr 11, 2017 10:36 AM IST
In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy, and Anuj Singhal, Basant Maheshwari, Author & Independent Market Expert shared his readings and outlook on specific stocks and sectors.
- Mar 06, 2017 03:28 PM IST
Gaurang Shah of Geojit BNP Paribas is positive on Container Corporation of India and Blue Dart.
- Sep 30, 2015 03:23 PM IST
Kunal Bothra of LKP Securities recommends buying Blue Dart with a target of Rs 8000.
- Jul 30, 2015 01:21 PM IST
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Bank of Baroda, Cipla, Jyothy Labs, Blue Dart, Wabco India and Oriental Bank of Commerce (OBC).
- Jul 30, 2015 12:14 PM IST
Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Gati and Blue Dart Express and feels that there is money in these stocks.
- Jul 20, 2015 02:46 PM IST
According to Vishal Malkan of malkansview.com, one may hold Blue Dart Express.
- May 08, 2015 10:33 AM IST
Rajat Bose of rajatkbose.com is of the view that above Rs 405, Bharti Airtel may test Rs 409-411.
- Nov 13, 2014 03:23 PM IST
Pankaj Jain, Director at Sunteck Wealthmax Capital is of the view that one can buy Hitachi Home, Blue Dart.
- Nov 26, 2012 11:00 AM IST
Invest in Blue Dart Express around Rs 1900 with a view of 6-8 months, says SP Tulsian, sptulsian.com.
- Nov 25, 2012 10:11 AM IST
Shares of multi-national companies (MNCs) will be in focus in the next few weeks as many of them will be required to either reduce promoter shareholding to a regulatory cap of 75 per cent or get delisted.
- Nov 23, 2012 11:37 AM IST
Buy Blue Dart, says PN Vijay, Portfolio Manager, askpnvijay.com. It is a leader in one of India‘s fastest growing businesses and strong parented and all that adds up to a nice cocktail.
- Nov 23, 2012 10:34 AM IST
PN Vijay, Portfolio Manager, askpnvijay.com, says that companies like Cipla and Ranbaxy would be largely affected by the pricing policy because they have large presence in domestic life saving drugs space and to some extent affect will be seen on Lupin.
- Nov 20, 2012 03:32 PM IST
Jagannadham Thununguntla, SMC Global, says that Honeywell Automation has the makings of all a perfect case study of delisting case.